At the time of writing, Neumora Therapeutics Inc [NMRA] stock is trading at $2.22, saw in change for the day. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NMRA shares have gain 35.78% over the last week, with a monthly amount glided 6.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Neumora Therapeutics Inc [NASDAQ: NMRA] stock has seen the most recent analyst activity on January 12, 2026, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $8. Previously, RBC Capital Mkts upgraded its rating to Outperform on December 01, 2025, and kept the price target unchanged to $7. On October 27, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $14 on the stock. JP Morgan downgraded its rating to an Underweight. BofA Securities downgraded its rating to an Underperform but $1 remained the price target by the analyst firm on April 02, 2025. William Blair downgraded its rating to Mkt Perform for this stock on March 10, 2025. In a note dated March 07, 2025, Stifel downgraded a Hold rating on this stock and revised its target price from $6 to $2.
For the past year, the stock price of Neumora Therapeutics Inc fluctuated between $0.61 and $3.25. Currently, Wall Street analysts expect the stock to reach $7.25 within the next 12 months. Neumora Therapeutics Inc [NASDAQ: NMRA] shares were valued at $2.22 at the most recent close of the market. An investor can expect a potential return of 226.58% based on the average NMRA price forecast.
Analyzing the NMRA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.33, Equity is -1.14 and Total Capital is -1.62. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Neumora Therapeutics Inc [NASDAQ:NMRA] has a current ratio of 6.85. Further, the Quick Ratio stands at 6.85, while the Cash Ratio is 4.99.
Transactions by insiders
Recent insider trading involved Aurora Daljit Singh, that happened on Nov 11 ’25 when 0.11 million shares were sold. Director, Aurora Family Trust completed a deal on Nov 11 ’25 to buy 0.11 million shares. Meanwhile, Director Burow Kristina bought 1.92 million shares on Oct 27 ’25.
